These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18251358)

  • 21. Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate.
    Verheul HA; Blok LJ; Burger CW; Hanifi-Moghaddam P; Kloosterboer HJ
    Reprod Sci; 2007 Feb; 14(2):160-8. PubMed ID: 17636227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.
    Simon J; Nachtigall L; Gut R; Lang E; Archer DF; Utian W
    Obstet Gynecol; 2008 Nov; 112(5):1053-60. PubMed ID: 18978105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, multiple-dose parallel study to compare the pharmacokinetic parameters of synthetic conjugated estrogens, A, administered as oral tablet or vaginal cream.
    Bhamra RK; Margolis MB; Liu JH; Hendy CH; Jenkins RG; DiLiberti CE
    Menopause; 2011 Apr; 18(4):393-9. PubMed ID: 21107298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of sexual intercourse on the absorption of levonorgestrel after vaginal administration of 0.75 mg in Carraguard gel: a randomized, cross-over, pharmacokinetic study.
    Brache V; Croxatto H; Kumar N; Sitruk-Ware R; Cochón L; Schiappacasse V; Sivin I; Muñoz C; Maguire R; Faundes A
    Contraception; 2009 Feb; 79(2):150-4. PubMed ID: 19135574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA; Schaefers M; Uddin A; Utian WH
    Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial.
    Valiati B; Capp E; Edelweiss MI; de Freitas FM; Wender MC
    Maturitas; 2009 Jan; 62(1):81-4. PubMed ID: 19097715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial.
    Schaefers M; Muysers C; Alexandersen P; Christiansen C
    Menopause; 2009; 16(3):559-65. PubMed ID: 19423999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of microtrauma after sexual intercourse.
    Norvell MK; Benrubi GI; Thompson RJ
    J Reprod Med; 1984 Apr; 29(4):269-71. PubMed ID: 6716372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone therapy effects on social behavior and activity levels of surgically postmenopausal cynomolgus monkeys.
    Shively CA; Wood CE; Register TC; Willard SL; Lees CJ; Chen H; Sitruk-Ware RL; Tsong YY; Cline JM
    Psychoneuroendocrinology; 2007; 32(8-10):981-90. PubMed ID: 17768011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of skin-to-skin contact, application site washing, and sunscreen use on the pharmacokinetics of estradiol from a metered-dose transdermal spray.
    Schumacher RJ; Gattermeir DJ; Peterson CA; Wisdom C; Day WW
    Menopause; 2009; 16(1):177-83. PubMed ID: 18779758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of sexual intercourse in hematuria and proteinuria in males and females.
    Hosseini SR; Mohseni MG; Atharikia D
    Urol Int; 2008; 81(3):271-4. PubMed ID: 18931541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
    Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
    Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of collagen by estradiol: difference between sun-protected and photodamaged human skin in vivo.
    Rittié L; Kang S; Voorhees JJ; Fisher GJ
    Arch Dermatol; 2008 Sep; 144(9):1129-40. PubMed ID: 18794456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):907-22. PubMed ID: 19436225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of endogenous estradiol levels on bone resorption and bone mineral density in healthy postmenopausal women: a prospective study.
    Mastaglia SR; Bagur A; Royer M; Yankelevich D; Sayegh F; Oliveri B
    Climacteric; 2009 Feb; 12(1):49-58. PubMed ID: 19003631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term oral dehydroepiandrosterone treatment in postmenopausal women.
    Stanczyk FZ; Slater CC; Ramos DE; Azen C; Cherala G; Hakala C; Abraham G; Roy S
    Menopause; 2009; 16(2):272-8. PubMed ID: 19098687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.
    Phillips TJ; Symons J; Menon S;
    J Am Acad Dermatol; 2008 Sep; 59(3):397-404.e3. PubMed ID: 18625536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause.
    Casanova G; Radavelli S; Lhullier F; Spritzer PM
    Fertil Steril; 2009 Aug; 92(2):605-12. PubMed ID: 18706557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.